LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

Search

aTyr Pharma Inc

Closed

3.33 5.05

Overview

Share price change

24h

Current

Min

3.16

Max

3.44

Key metrics

By Trading Economics

Income

2.3M

-15M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+596.2% upside

Dividends

By Dow Jones

Next Earnings

14 maj 2025

aTyr Pharma Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 maj 2025, 23:59 UTC

Top News
Earnings

Naver 1Q Net Slumps on Higher Costs

8 maj 2025, 23:39 UTC

Earnings

OCBC 1Q Net Down on Lower Interest Income

8 maj 2025, 23:01 UTC

Earnings

Macquarie Raises Dividend After 5.5% Rise in Annual Profit -- Update

8 maj 2025, 22:52 UTC

Earnings

REA Expects Annual Listings Growth Despite April Decline

8 maj 2025, 22:46 UTC

Earnings

Macquarie Raises Dividend After 5.5% Rise in Annual Profit

8 maj 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

8 maj 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Tariffs Fears Ease -- Market Talk

8 maj 2025, 23:41 UTC

Market Talk

Gold Rises on Possible Technical Recovery; Gains May be Capped by Risk-on Mood -- Market Talk

8 maj 2025, 23:30 UTC

Earnings

Itau Unibanco 1Q Rev BRL45.02B >ITUB

8 maj 2025, 23:29 UTC

Earnings

Itau Unibanco 1Q EPS BRL1.03 >ITUB

8 maj 2025, 23:22 UTC

Earnings

Naver 1Q Net Profit Largely Met FactSet-Compiled Consensus

8 maj 2025, 23:22 UTC

Earnings

Naver 1Q Net KRW423.70B Vs. Net KRW555.80B >035420.SE

8 maj 2025, 23:21 UTC

Earnings

Naver 1Q Oper Pft KRW505.30B Vs. Pft KRW439.30B >035420.SE

8 maj 2025, 23:21 UTC

Earnings

Naver 1Q Rev KRW2.787T Vs. KRW2.526T >035420.SE

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.35B Vs. S$2.44B >O39.SG

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Total Income S$3.66B Vs. S$3.63B >O39.SG

8 maj 2025, 23:17 UTC

Earnings

Oversea-Chinese Banking Corp. 1Q Net S$1.88B Vs. Net S$1.98B >O39.SG

8 maj 2025, 23:05 UTC

Market Talk

ANZ Could Cut Dividend by 10% From 2H -- Market Talk

8 maj 2025, 23:05 UTC

Market Talk

Global Equities Roundup: Market Talk

8 maj 2025, 22:28 UTC

Earnings

REA Expects FY 2025 Listings Growth of 1-2%

8 maj 2025, 22:28 UTC

Earnings

REA Says April Listings Decline Reflects Year Ago Strength, Timing of Easter and Election

8 maj 2025, 22:27 UTC

Earnings

REA Says April Sydney, Melbourne Listings Both Down 16% on Year

8 maj 2025, 22:27 UTC

Earnings

REA Says April Residential Listings Fell by 11% on Year

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Operating Expenses A$176 Million, Up 12% on Year

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Free Cash Flow A$132 Million, Up 19% on Year

8 maj 2025, 22:26 UTC

Earnings

REA 3Q Operating Ebitda A$199 Million, Up 12% on Year

8 maj 2025, 22:26 UTC

Earnings

REA Nine-Months Free Cash Flow A$389 Million, Up 21% on Year

8 maj 2025, 22:25 UTC

Earnings

REA Nine-Months Operating Expenses A$513 Million, Up 15% on Year

8 maj 2025, 22:25 UTC

Earnings

REA Nine-Months Operating Ebitda A$734 Million, Up 19% on Year

8 maj 2025, 22:25 UTC

Earnings

REA 3Q Revenue A$374 Million, Up 12% on Year

Peer Comparison

Price change

aTyr Pharma Inc Forecast

Price Target

By TipRanks

596.2% upside

12 Months Forecast

Average 22 USD  596.2%

High 35 USD

Low 16 USD

Based on 7 Wall Street analysts offering 12 month price targets foraTyr Pharma Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Operating profit

$

About aTyr Pharma Inc

aTyr Pharma Inc